Likeness Rx publishes compounded semaglutide and tirzepatide offers with four supply terms. Semaglutide starts at a $79 monthly equivalent on the twelve-month option, billed at $948; tirzepatide’s corresponding figures are $129 and $1,548. The one-month options are $139 and $199.
We checked the GLP-1 page on October 5, 2026 and read its published plan ladder and FAQ language. We did not place an order or test clinical care. The value of this review is the distinction between the advertised equivalent, the selected payment and the prescription decision that follows an assessment.
Follow the semaglutide payment ladder
The page lists $139 for one month, $327 for three months, $534 for six months and $948 for twelve months. Their displayed monthly equivalents are $139, $109, $89 and $79. The lower equivalent comes with a different term and a different amount collected.
A longer plan may look less expensive on a monthly comparison while requiring more money up front. Ask what happens if clinical circumstances change during that term, how dispensing is scheduled and whether unused supply changes the refund position. The selector alone does not settle those questions.
Read tirzepatide as a separate set of choices
The tirzepatide selector shows $199 for one month, $477 for three months, $834 for six months and $1,548 for twelve months. That corresponds to $199, $159, $139 and $129 per month. Do not transfer the semaglutide checkout total to this medicine just because the term buttons look identical.
The price comparison is administrative information, not a recommendation to choose one medicine. The clinician must assess whether treatment is appropriate and what preparation is justified. A more expensive or less expensive listing cannot answer that clinical question.
Automatic renewal makes the selected term important
Likeness says the plan renews on the selected interval until canceled. A reader choosing twelve months should therefore ask about the next term’s full collection, not only a small monthly display. Save the renewal date and the mechanism for stopping the next charge.
Cancellation language does not establish that a medication already prescribed or dispensed can be returned. Ask for the policy attached to the chosen plan, including the point at which processing becomes final. We did not attempt cancellation and cannot report how quickly a request would be handled.
The online visit is an assessment, not guaranteed access
The page describes a short online visit and review by a licensed provider. It also describes care-team messaging. These are advertised process features. We did not measure assessment time, confirm an assigned clinician or send a clinical support question to observe its handling.
Bring the relevant medication and health-history information to the assessment, and ask how the practice handles circumstances that require more evaluation. A checkout selector should not be treated as a diagnosis or as assurance that the chosen medicine will be prescribed.
Verify the dispensed product and delivery record
The offer concerns compounded medicines. FDA does not approve compounded products or review them for safety, effectiveness and quality before marketing. The actual pharmacy record, concentration and dispensing instructions matter more than a promotional image.
A prepaid billing term does not necessarily mean the whole term’s medication is shipped at once. Confirm the quantity in each delivery, refill steps and storage instructions supplied by the pharmacy. Do not infer a storage limit or administration schedule from the duration of a subscription.
Use the review before following the placement
Likeness occupies our third featured position, after CoreAge and SuperHealthy. That position and its score are publisher preferences. They do not summarize collected patient ratings or establish comparative medical effectiveness. Each featured name opens the same native review format on this site.
The most useful contrast is in the documents: Likeness’s explicit prepaid totals, SuperHealthy’s current refill language and the CoreAge campaign’s starting-price presentation. Put the selected documents next to one another and resolve the unanswered details rather than choosing from the order alone.
The service record
- Medication scope
- Compounded preparations; not FDA-approved
- Assessment
- Online health history followed by licensed-provider review; approval is conditional
- Pharmacy and shipping
- Delivery after prescribing advertised; confirm pharmacy, quantity and schedule
Costs and commitments
- Advertised program
- Semaglutide from $79/month; tirzepatide from $129/month
- Medication
- One-month options: semaglutide $139, tirzepatide $199
- Separate membership
- The page presents selected program prices; confirm that all included services are on the final invoice
- Insurance
- Cash-pay program; HSA/FSA acceptance advertised, individual eligibility to confirm
- Cancellation
- The page says the selected term renews automatically. Confirm the renewal date and cancellation deadline for that term.
- Refunds
- The provider advertises a refund when no prescription is approved. Check the selected order policy and any later-order exclusions.
What stands out, and what to clarify
Published features
- Full totals published for four term lengths
- Separate prices for the two medicines
- Clinical review and care-team messaging described
Questions and limits
- The lowest monthly equivalent requires a larger payment
- A twelve-month term is not proof of twelve monthly collections
- No independent fulfillment or outcome testing in this review
A closer look at the offer
A selector that exposes the arithmetic
The page pairs the monthly equivalent with the full amount billed for the selected term. Use that total in the worksheet instead of entering only the lowest headline.
A term is not a dispensing instruction
The billing period does not independently identify how much is delivered at once, the concentration or a clinical dosing schedule. Those details require the actual prescription and order.
Before you proceed
- The site describes online licensed-provider review and care-team messaging. Confirm the assigned prescriber, dispensing pharmacy and follow-up.
Confirm these details with the selected provider. Response times, approval and fulfillment were not tested for this review.
Sources and review boundaries
Source record: 2026-10-05. Provider descriptions document advertised services. They do not establish patient outcomes or independent verification of every operational claim.
This is an editorial source review, not individual medical advice. Compounded medications are not FDA-approved. No intake, prescription, shipment or patient outcome was tested.